Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL156318

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
COc1cc2c(cc1OC)CN(CCNC(=O)c1ccccc1NC(=O)c1ccc(C3CCCCC3)cc1)CC2

Basic Information

ChEMBL ID CHEMBL156318
Phase Preclinical
Structure Type MOL
InChI Key FRKRVYQJFNOVNC-UHFFFAOYSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names

Molecular Properties

541.7
MW (Da)
5.79
ALogP
5
HBA
2
HBD
79.9
PSA (Ų)
0.36
QED
2
Ro5 Violations
9
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C33H39N3O4
MW 541.69
Aromatic Rings 3
Heavy Atoms 40
NP-Likeness -1.02

Activity Summary

IC50 1 meas. best 5.8

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
EMT6
CHEMBL614294
IC50 5.8 5.8 1600.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
EMT6 IC50 = 1600.0 nM 5.8 Reversal effect on the accumulation of [3H]- daunorubicin in mouse mammary carci... 10098671

Literature References

PubMed DOI Target Context # Activities
10098671 10.1016/s0960-894x(99)00030-x EMT6 1

Data from ChEMBL 36 via Core Engine